Valley Health First in Bergen County to Offer NanoKnife® for Prostate Cancer
- In a significant advancement for prostate cancer treatment, The Valley Hospital in Paramus, New Jersey, has become the first hospital in Bergen County to utilize the NanoKnife® System,...
- Traditional treatments often involve removing the entire prostate gland, a procedure that, while effective, can lead to complications such as incontinence and erectile dysfunction.
- “This groundbreaking treatment represents a major step forward in offering men less invasive options for prostate cancer management,” explained Dr.
In a significant advancement for prostate cancer treatment, The Valley Hospital in Paramus, New Jersey, has become the first hospital in Bergen County to utilize the NanoKnife® System, a minimally invasive technology offering a new option for men diagnosed with the disease. The first procedure using the system was successfully completed on , by a team led by Nick W. Liu, MD, Medical Director of Urology, and David T. Ahlborn, MD.
Prostate cancer remains a leading health concern for men. Traditional treatments often involve removing the entire prostate gland, a procedure that, while effective, can lead to complications such as incontinence and erectile dysfunction. The NanoKnife® System, formally known as Irreversible Electroporation (IRE), presents a potentially less disruptive alternative, particularly for men whose cancer is confined to a small area of the prostate.
“This groundbreaking treatment represents a major step forward in offering men less invasive options for prostate cancer management,” explained Dr. Liu. “Prostate cancer is the only cancer that is currently treated by removing the entire organ, which may not be necessary if the cancer is detected early.”
How NanoKnife® Works: A Targeted Approach
The NanoKnife® System employs a precise method of destroying cancer cells. Unlike radiation or surgery that can impact surrounding healthy tissue, IRE uses electrical pulses to create permanent pores in the membranes of cancer cells. These pores disrupt the cells’ ability to function, leading to their death, while sparing nearby healthy tissue. This targeted approach is particularly beneficial for patients with localized prostate cancer, where preserving the functionality of the prostate is a priority.
“The NanoKnife® System allows doctors to treat the cancer precisely, preserve the healthy areas of the prostate, and limit postoperative complications,” Dr. Liu stated. This precision is achieved through careful planning and image guidance, ensuring that the electrical pulses are delivered directly to the cancerous tissue.
Valley Hospital’s Commitment to Advanced Cancer Care
The introduction of the NanoKnife® System at Valley Hospital underscores the institution’s dedication to providing cutting-edge, patient-centered cancer care. “I am incredibly proud of our entire team, whose skill, dedication, and teamwork have made this milestone possible,” Dr. Liu said. “This achievement reflects Valley’s ongoing commitment to bringing leading-edge, patient-centered cancer care to our community.”
The hospital’s urologic oncology team emphasizes the importance of early detection and preventative screenings. Valley’s board-certified urologists offer comprehensive medical and surgical services for both men and women dealing with diseases of the urinary system, as well as reproductive health issues in men. They actively promote screenings and wellness initiatives aimed at identifying urologic cancers at their most treatable stages.
Beyond Treatment: A Multidisciplinary Approach
Dr. Ahlborn highlighted the comprehensive nature of Valley’s urologic oncology program. “With a focus on state-of-the-art, compassionate urologic medical and surgical care and the multidisciplinary treatment of patients with urologic cancers, we provide the latest advances in diagnostics, treatment, continuing care, and disease surveillance.” This multidisciplinary approach ensures that patients receive holistic care tailored to their individual needs.
What This Means for Patients
The availability of the NanoKnife® System at Valley Hospital offers a new avenue of hope for men diagnosed with localized prostate cancer. While not suitable for all patients, it provides a potentially less invasive option with the goal of minimizing side effects and preserving quality of life. The decision to pursue NanoKnife® treatment, like any cancer treatment, should be made in consultation with a qualified urologist who can assess the individual’s specific case and determine the most appropriate course of action.
For individuals seeking more information about Valley’s urologic oncology program or wishing to schedule an appointment, resources are available at ValleyHealth.com/UrologicOncology or by calling .
The development and availability of technologies like the NanoKnife® System represent ongoing progress in the fight against prostate cancer, offering men increasingly sophisticated and targeted treatment options.